COVID-19
Although the data hasn’t been released yet, analysts are making predictions based on what little they do know.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 9, 2020.
The fastest way to get a safe, effective vaccine for COVID-19 to physicians and patients is to build upon an existing vaccine with an already-established manufacturing and supply chain…or to revolutionize the manufacturing process.
AstraZeneca made an announcement describing its internal and partnering efforts to battle COVID-19, the disease caused by the novel coronavirus SARS-CoV-2.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 8, 2020.
As the pandemic progresses, researchers are attacking the virus from every angle, and also learning more and more about how and why the virus affects who it does.
The United States leads the world in biotech innovation, but does it also lead the world in the development of COVID-19 diagnostics, vaccines and therapeutics?
It would be used to fill in the gaps seen in funding for vaccines, treatments and diagnostic testing.
The CDC findings were based on an analysis of 2,572 known juvenile cases of COVID-19 that were part of a batch of 149,760 laboratory-confirmed COVID-19 cases.
While the world is working to slow the COVID-19 pandemic by social isolation and quarantine, numerous companies globally are working to develop a vaccine against the virus.
PRESS RELEASES